Compare Stocks

4 / 10
Try these comparisons:

Stock Comparison

IEX vs DHR vs EMR vs TMO

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
IEX
IDEX Corporation

Industrial - Machinery

IndustrialsNYSE • US
Market Cap$15.97B
5Y Perf.+34.8%
DHR
Danaher Corporation

Medical - Diagnostics & Research

HealthcareNYSE • US
Market Cap$124.33B
5Y Perf.+18.9%
EMR
Emerson Electric Co.

Industrial - Machinery

IndustrialsNYSE • US
Market Cap$79.02B
5Y Perf.+131.2%
TMO
Thermo Fisher Scientific Inc.

Medical - Diagnostics & Research

HealthcareNYSE • US
Market Cap$176.36B
5Y Perf.+35.9%

IEX vs DHR vs EMR vs TMO — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
IEX logoIEX
DHR logoDHR
EMR logoEMR
TMO logoTMO
IndustryIndustrial - MachineryMedical - Diagnostics & ResearchIndustrial - MachineryMedical - Diagnostics & Research
Market Cap$15.97B$124.33B$79.02B$176.36B
Revenue (TTM)$3.53B$24.78B$18.32B$45.20B
Net Income (TTM)$508M$3.69B$2.44B$6.86B
Gross Margin44.4%60.7%52.7%39.4%
Operating Margin20.8%21.0%19.8%17.8%
Forward P/E25.5x20.8x21.7x19.1x
Total Debt$1.82B$18.42B$13.76B$40.85B
Cash & Equiv.$580M$4.62B$1.54B$9.86B

IEX vs DHR vs EMR vs TMOLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

IEX
DHR
EMR
TMO
StockMay 20May 26Return
IDEX Corporation (IEX)100134.8+34.8%
Danaher Corporation (DHR)100118.9+18.9%
Emerson Electric Co. (EMR)100231.2+131.2%
Thermo Fisher Scien… (TMO)100135.9+35.9%

Price return only. Dividends and distributions are not included.

Quick Verdict: IEX vs DHR vs EMR vs TMO

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: IEX leads in 3 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Emerson Electric Co. is the stronger pick specifically for dividend income and shareholder returns and recent price momentum and sentiment. DHR and TMO also each lead in at least one category. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
IEX
IDEX Corporation
The Growth Play

IEX carries the broadest edge in this set and is the clearest fit for growth exposure and valuation efficiency.

  • Rev growth 5.8%, EPS growth -3.5%, 3Y rev CAGR 2.8%
  • PEG 4.77 vs DHR's 34.35
  • Beta 0.95, yield 1.3%, current ratio 2.86x
  • 5.8% revenue growth vs DHR's 2.9%
Best for: growth exposure and valuation efficiency
DHR
Danaher Corporation
The Defensive Pick

DHR is the clearest fit if your priority is sleep-well-at-night.

  • Lower volatility, beta 0.94, Low D/E 35.1%, current ratio 1.87x
  • Beta 0.94 vs EMR's 1.52, lower leverage
Best for: sleep-well-at-night
EMR
Emerson Electric Co.
The Income Pick

EMR is the #2 pick in this set and the best alternative if income & stability is your priority.

  • Dividend streak 37 yrs, beta 1.52, yield 1.5%
  • 1.5% yield, 37-year raise streak, vs TMO's 0.4%
  • +30.4% vs DHR's -8.3%
Best for: income & stability
TMO
Thermo Fisher Scientific Inc.
The Long-Run Compounder

TMO is the clearest fit if your priority is long-term compounding.

  • 229.1% 10Y total return vs EMR's 206.6%
  • 15.2% margin vs EMR's 13.3%
Best for: long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthIEX logoIEX5.8% revenue growth vs DHR's 2.9%
ValueIEX logoIEXPEG 4.77 vs 4.81
Quality / MarginsTMO logoTMO15.2% margin vs EMR's 13.3%
Stability / SafetyDHR logoDHRBeta 0.94 vs EMR's 1.52, lower leverage
DividendsEMR logoEMR1.5% yield, 37-year raise streak, vs TMO's 0.4%
Momentum (1Y)EMR logoEMR+30.4% vs DHR's -8.3%
Efficiency (ROA)IEX logoIEX7.3% ROA vs DHR's 4.5%, ROIC 10.4% vs 5.9%

IEX vs DHR vs EMR vs TMO — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

IEXIDEX Corporation
FY 2025
Health And Science Technologies
43.2%$1.5B
Fluid And Metering Technologies
35.3%$1.2B
Fire And Safety Diversified Products
21.5%$745M
DHRDanaher Corporation
FY 2025
Revenue from Contract with Customer, Measurement, Recurring
81.9%$20.1B
Revenue from Contract with Customer, Measurement, Nonrecurring
18.1%$4.4B
EMREmerson Electric Co.
FY 2025
Intelligent Devices
68.5%$12.4B
Software and Control
31.5%$5.7B
TMOThermo Fisher Scientific Inc.
FY 2025
Consumables
41.9%$18.7B
Service
41.7%$18.6B
Instruments
16.4%$7.3B

IEX vs DHR vs EMR vs TMO — Financial Metrics

Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLEMRLAGGINGTMO

Income & Cash Flow (Last 12 Months)

DHR leads this category, winning 3 of 6 comparable metrics.

TMO is the larger business by revenue, generating $45.2B annually — 12.8x IEX's $3.5B. Profitability is closely matched — net margins range from 15.2% (TMO) to 13.3% (EMR). On growth, IEX holds the edge at +8.9% YoY revenue growth, suggesting stronger near-term business momentum.

MetricIEX logoIEXIDEX CorporationDHR logoDHRDanaher Corporati…EMR logoEMREmerson Electric …TMO logoTMOThermo Fisher Sci…
RevenueTrailing 12 months$3.5B$24.8B$18.3B$45.2B
EBITDAEarnings before interest/tax$945M$7.2B$4.7B$10.5B
Net IncomeAfter-tax profit$508M$3.7B$2.4B$6.9B
Free Cash FlowCash after capex$611M$5.3B$3.1B$6.7B
Gross MarginGross profit ÷ Revenue+44.4%+60.7%+52.7%+39.4%
Operating MarginEBIT ÷ Revenue+20.8%+21.0%+19.8%+17.8%
Net MarginNet income ÷ Revenue+14.4%+14.9%+13.3%+15.2%
FCF MarginFCF ÷ Revenue+17.3%+21.4%+17.0%+14.9%
Rev. Growth (YoY)Latest quarter vs prior year+8.9%+3.7%+2.9%+6.2%
EPS Growth (YoY)Latest quarter vs prior year+27.8%+9.8%+28.2%+11.3%
DHR leads this category, winning 3 of 6 comparable metrics.

Valuation Metrics

TMO leads this category, winning 3 of 7 comparable metrics.

At 26.8x trailing earnings, TMO trades at a 23% valuation discount to EMR's 34.9x P/E. Adjusting for growth (PEG ratio), IEX offers better value at 6.27x vs DHR's 34.35x — a lower PEG means you pay less per unit of expected earnings growth.

MetricIEX logoIEXIDEX CorporationDHR logoDHRDanaher Corporati…EMR logoEMREmerson Electric …TMO logoTMOThermo Fisher Sci…
Market CapShares × price$16.0B$124.3B$79.0B$176.4B
Enterprise ValueMkt cap + debt − cash$17.2B$138.1B$91.2B$207.4B
Trailing P/EPrice ÷ TTM EPS33.51x34.85x34.92x26.75x
Forward P/EPrice ÷ next-FY EPS est.25.52x20.82x21.71x19.11x
PEG RatioP/E ÷ EPS growth rate6.27x34.35x7.73x12.67x
EV / EBITDAEnterprise value multiple18.58x18.21x18.07x19.04x
Price / SalesMarket cap ÷ Revenue4.62x5.06x4.39x3.96x
Price / BookPrice ÷ Book value/share4.02x2.38x3.94x3.34x
Price / FCFMarket cap ÷ FCF25.89x23.64x29.63x28.02x
TMO leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

IEX leads this category, winning 6 of 9 comparable metrics.

TMO delivers a 13.2% return on equity — every $100 of shareholder capital generates $13 in annual profit, vs $7 for DHR. DHR carries lower financial leverage with a 0.35x debt-to-equity ratio, signaling a more conservative balance sheet compared to TMO's 0.76x. On the Piotroski fundamental quality scale (0–9), IEX scores 7/9 vs TMO's 6/9, reflecting strong financial health.

MetricIEX logoIEXIDEX CorporationDHR logoDHRDanaher Corporati…EMR logoEMREmerson Electric …TMO logoTMOThermo Fisher Sci…
ROE (TTM)Return on equity+12.6%+7.1%+12.1%+13.2%
ROA (TTM)Return on assets+7.3%+4.5%+5.8%+6.4%
ROICReturn on invested capital+10.4%+5.9%+8.2%+7.5%
ROCEReturn on capital employed+11.6%+7.0%+10.0%+9.1%
Piotroski ScoreFundamental quality 0–97776
Debt / EquityFinancial leverage0.45x0.35x0.68x0.76x
Net DebtTotal debt minus cash$1.2B$13.8B$12.2B$31.0B
Cash & Equiv.Liquid assets$580M$4.6B$1.5B$9.9B
Total DebtShort + long-term debt$1.8B$18.4B$13.8B$40.9B
Interest CoverageEBIT ÷ Interest expense11.33x18.13x6.46x5.89x
IEX leads this category, winning 6 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

EMR leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in EMR five years ago would be worth $15,945 today (with dividends reinvested), compared to $7,893 for DHR. Over the past 12 months, EMR leads with a +30.4% total return vs DHR's -8.3%. The 3-year compound annual growth rate (CAGR) favors EMR at 20.7% vs DHR's -5.5% — a key indicator of consistent wealth creation.

MetricIEX logoIEXIDEX CorporationDHR logoDHRDanaher Corporati…EMR logoEMREmerson Electric …TMO logoTMOThermo Fisher Sci…
YTD ReturnYear-to-date+20.4%-23.6%+4.3%-19.8%
1-Year ReturnPast 12 months+20.9%-8.3%+30.4%+16.8%
3-Year ReturnCumulative with dividends+5.9%-15.5%+75.9%-11.7%
5-Year ReturnCumulative with dividends+0.7%-21.1%+59.5%+2.8%
10-Year ReturnCumulative with dividends+189.3%+219.3%+206.6%+229.1%
CAGR (3Y)Annualised 3-year return+1.9%-5.5%+20.7%-4.0%
EMR leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — IEX and DHR each lead in 1 of 2 comparable metrics.

DHR is the less volatile stock with a 0.94 beta — it tends to amplify market swings less than EMR's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IEX currently trades 96.0% from its 52-week high vs DHR's 72.3% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricIEX logoIEXIDEX CorporationDHR logoDHRDanaher Corporati…EMR logoEMREmerson Electric …TMO logoTMOThermo Fisher Sci…
Beta (5Y)Sensitivity to S&P 5000.95x0.94x1.52x1.10x
52-Week HighHighest price in past year$223.84$242.80$165.15$643.99
52-Week LowLowest price in past year$157.25$172.06$108.37$385.46
% of 52W HighCurrent price vs 52-week peak+96.0%+72.3%+85.4%+73.7%
RSI (14)Momentum oscillator 0–10067.633.061.343.1
Avg Volume (50D)Average daily shares traded713K4.2M2.8M1.9M
Evenly matched — IEX and DHR each lead in 1 of 2 comparable metrics.

Analyst Outlook

EMR leads this category, winning 2 of 2 comparable metrics.

Analyst consensus: IEX as "Hold", DHR as "Buy", EMR as "Buy", TMO as "Buy". Consensus price targets imply 40.6% upside for DHR (target: $247) vs 12.7% for IEX (target: $242). For income investors, EMR offers the higher dividend yield at 1.49% vs TMO's 0.36%.

MetricIEX logoIEXIDEX CorporationDHR logoDHRDanaher Corporati…EMR logoEMREmerson Electric …TMO logoTMOThermo Fisher Sci…
Analyst RatingConsensus buy/hold/sellHoldBuyBuyBuy
Price TargetConsensus 12-month target$242.14$247.00$161.92$654.67
# AnalystsCovering analysts29424142
Dividend YieldAnnual dividend ÷ price+1.3%+0.7%+1.5%+0.4%
Dividend StreakConsecutive years of raises231378
Dividend / ShareAnnual DPS$2.82$1.23$2.10$1.69
Buyback YieldShare repurchases ÷ mkt cap+1.6%+2.5%+1.6%+1.7%
EMR leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

EMR leads in 2 of 6 categories (Total Returns, Analyst Outlook). DHR leads in 1 (Income & Cash Flow). 1 tied.

Best OverallEmerson Electric Co. (EMR)Leads 2 of 6 categories
Loading custom metrics...

IEX vs DHR vs EMR vs TMO: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is IEX or DHR or EMR or TMO a better buy right now?

For growth investors, IDEX Corporation (IEX) is the stronger pick with 5.

8% revenue growth year-over-year, versus 2. 9% for Danaher Corporation (DHR). Thermo Fisher Scientific Inc. (TMO) offers the better valuation at 26. 8x trailing P/E (19. 1x forward), making it the more compelling value choice. Analysts rate Danaher Corporation (DHR) a "Buy" — based on 42 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — IEX or DHR or EMR or TMO?

On trailing P/E, Thermo Fisher Scientific Inc.

(TMO) is the cheapest at 26. 8x versus Emerson Electric Co. at 34. 9x. On forward P/E, Thermo Fisher Scientific Inc. is actually cheaper at 19. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: IDEX Corporation wins at 4. 77x versus Danaher Corporation's 34. 35x.

03

Which is the better long-term investment — IEX or DHR or EMR or TMO?

Over the past 5 years, Emerson Electric Co.

(EMR) delivered a total return of +59. 5%, compared to -21. 1% for Danaher Corporation (DHR). Over 10 years, the gap is even starker: TMO returned +229. 1% versus IEX's +189. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — IEX or DHR or EMR or TMO?

By beta (market sensitivity over 5 years), Danaher Corporation (DHR) is the lower-risk stock at 0.

94β versus Emerson Electric Co. 's 1. 52β — meaning EMR is approximately 62% more volatile than DHR relative to the S&P 500. On balance sheet safety, Danaher Corporation (DHR) carries a lower debt/equity ratio of 35% versus 76% for Thermo Fisher Scientific Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — IEX or DHR or EMR or TMO?

By revenue growth (latest reported year), IDEX Corporation (IEX) is pulling ahead at 5.

8% versus 2. 9% for Danaher Corporation (DHR). On earnings-per-share growth, the picture is similar: Emerson Electric Co. grew EPS 17. 8% year-over-year, compared to -4. 7% for Danaher Corporation. Over a 3-year CAGR, EMR leads at 9. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — IEX or DHR or EMR or TMO?

Thermo Fisher Scientific Inc.

(TMO) is the more profitable company, earning 15. 1% net margin versus 12. 7% for Emerson Electric Co. — meaning it keeps 15. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DHR leads at 20. 9% versus 18. 2% for TMO. At the gross margin level — before operating expenses — DHR leads at 60. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is IEX or DHR or EMR or TMO more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, IDEX Corporation (IEX) is the more undervalued stock at a PEG of 4. 77x versus Danaher Corporation's 34. 35x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Thermo Fisher Scientific Inc. (TMO) trades at 19. 1x forward P/E versus 25. 5x for IDEX Corporation — 6. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DHR: 40. 6% to $247. 00.

08

Which pays a better dividend — IEX or DHR or EMR or TMO?

All stocks in this comparison pay dividends.

Emerson Electric Co. (EMR) offers the highest yield at 1. 5%, versus 0. 4% for Thermo Fisher Scientific Inc. (TMO).

09

Is IEX or DHR or EMR or TMO better for a retirement portfolio?

For long-horizon retirement investors, Danaher Corporation (DHR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

94), 0. 7% yield, +219. 3% 10Y return). Both have compounded well over 10 years (DHR: +219. 3%, TMO: +229. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between IEX and DHR and EMR and TMO?

These companies operate in different sectors (IEX (Industrials) and DHR (Healthcare) and EMR (Industrials) and TMO (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

IEX, DHR, EMR pay a dividend while TMO does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

IEX

Stable Dividend Mega-Cap

  • Sector: Industrials
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 8%
Run This Screen
Stocks Like

DHR

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Net Margin > 8%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

EMR

Stable Dividend Mega-Cap

  • Sector: Industrials
  • Market Cap > $100B
  • Net Margin > 8%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

TMO

Stable Dividend Mega-Cap

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Net Margin > 9%
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform IEX and DHR and EMR and TMO on the metrics below

Revenue Growth>
%
(IEX: 8.9% · DHR: 3.7%)
Net Margin>
%
(IEX: 14.4% · DHR: 14.9%)
P/E Ratio<
x
(IEX: 33.5x · DHR: 34.9x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.